Cyclerion Therapeutics Inc CYCN 價格預測與預測

Q: CYCN 的費波那契回檔水準是多少？

Cyclerion Therapeutics Inc 的費波那契回檔水準是 介於 61.8% 和 78.6% 之間。

Q: Cyclerion Therapeutics Inc 的 RSI 是多少？

Cyclerion Therapeutics Inc 的 RSI 目前為 55.77，表明處於 中立 狀態

首頁

股票

CYCN

預測

CYCN 股票價格預測

Cyclerion Therapeutics Inc

$6.38

311.61%

$4.83

收盤價：Apr 01, 16:00:00 GMT-4

$5.78

-9.4%

$-0.59

盤後：Apr 01, 20:00:00 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$1.55

開盤價

$5.43

當日範圍

$5.39 - $8.48

52週區間

$1.02 - $8.48

交易量

252.3M

平均成交量

1.5M

股息收益率

每股盈餘 (TTM)

-0.76

市值

$22.7M

什麼是 CYCN？

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 1 full-time employees. The company went IPO on 2019-03-18. The firm is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. The company is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The firm has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.

功能特性

資源

市場

According to analyst forecasts, we anticipate notable price fluctuations for CYCN in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $8.16. The lowest target is $8.08 and the highest is $8.4. Empower your investment choices with our cutting-edge, data-driven analysis!

CYCN 股價預測摘要

CYCN 的頂級分析師評級

根據 7 位分析師對 CYCN 的股票評級，更新於 May 01, 2023

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for CYCN. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: CYCN is a Buy candidate.

CYCN stock price ended at $1.55 on 星期二, after rising 6.90%

On the latest trading day Mar 31, 2026, the stock price of CYCN rose by 6.90%, climbing from $1.47 to $1.55. Throughout the session, the stock experienced a volatility of 6.16%, with prices fluctuating between a daily low of $1.46 and a high of $1.55. Alongside this price increase, trading volume also rose by 6.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 27.5K shares were traded, amounting to a market value of approximately $6.0M.

CYCN 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

CYCN 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 6.9%。整體而言，技術指標顯示中期後市趨勢為 Buy。

CYCN 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為CYCN生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 CYCN？



根據技術分析，Cyclerion Therapeutics Inc 的綜合信號為 Buy。Cyclerion Therapeutics Inc 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

CYCN 的費波那契回檔水準是多少？



Cyclerion Therapeutics Inc 的費波那契回檔水準是介於 61.8% 和 78.6% 之間。

Cyclerion Therapeutics Inc 的 RSI 是多少？



Cyclerion Therapeutics Inc 的 RSI 目前為 55.77，表明處於中立狀態

Cyclerion Therapeutics Inc 接下來 12 個月的價格是多少？



Cyclerion Therapeutics Inc CYCN 接下來 12 個月的價格預估為 $8.16。

Cyclerion Therapeutics Inc 預計會漲到多高？



據華爾街分析師稱，Cyclerion Therapeutics Inc 預計將達到 $8.4 的高預測值。

Cyclerion Therapeutics Inc (CYCN) 股票價格預測

CYCN 股價走勢圖